Carregant...
Uptake of new antidiabetic medicines in 11 European countries
BACKGROUND: Several new antidiabetic medicines (GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors) have been approved by the European Medicines Agency since 2006. The aim of this study was to evaluate the uptake of new antidiabetic medicines in European countries over a 10-year period...
Guardat en:
| Publicat a: | BMC Endocr Disord |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8235847/ https://ncbi.nlm.nih.gov/pubmed/34172020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-021-00798-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|